Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis.
about
Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort studyGenetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to managementRole of cytokines and chemokines in non-alcoholic fatty liver diseaseCo-Administration of Cholesterol-Lowering Probiotics and Anthraquinone from Cassia obtusifolia L. Ameliorate Non-Alcoholic Fatty LiverNonalcoholic fatty liver disease: Diagnostic biomarkers.Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-reviewGreen tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty ratsMolecular pathways in non-alcoholic fatty liver disease.Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.Antiresistin RNA Oligonucleotide Ameliorates Diet-Induced Nonalcoholic Fatty Liver Disease in Mice through Attenuating Proinflammatory Cytokines.Physiology and pathophysiology of liver lipid metabolism.Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease.Noninvasive diagnosis of pediatric nonalcoholic fatty liver diseaseNon-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).Serum biomarkers in nonalcoholic steatohepatitis: value for assessing drug effects?Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Nonalcoholic steatohepatitis and insulin resistance in childrenNon-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives.Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.The Nutraceutic Silybin Counteracts Excess Lipid Accumulation and Ongoing Oxidative Stress in an In Vitro Model of Non-Alcoholic Fatty Liver Disease Progression.Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease.Liver volume and hepatic adiposity in childhood: relations to body growth and visceral fat.
P2860
Q24658538-D5CBDD1E-788F-4A84-9C63-38636CAC5BB3Q26741557-63221B3C-4473-4988-99AF-1B830CCDE754Q26830328-3718CD44-F0FC-4BFE-9E12-257DB59310D5Q27317549-4672E63A-14A2-4A8F-9E15-42DD07D49123Q33706254-3E6B3E8D-9ECE-4165-8D7D-AA2FA7EF9ED2Q33731768-1CBF6BFE-F0E0-4BCB-A485-3DEB9E54DCB8Q33786020-E7A55A80-303D-4F27-970E-CE1028F4CC3AQ33890230-B631D9D2-8361-430B-93A0-301AE4CE982EQ34830398-8F3E4951-975E-4471-A82F-5AEAC6001F77Q35422218-677E292C-53DB-4481-975D-17EBF6DB0237Q35662655-7E7129BB-2924-40C7-B354-65B65B186855Q35670195-3335E462-BF75-42EB-8A50-DB4777400811Q36660316-126EB16A-215D-45AC-AB5C-E32C4DEBA726Q37613375-248F0B93-1BBB-497A-9158-47E553903141Q37624585-C6333DFE-538B-4166-AB60-27DE0FD2E257Q38066240-A48F1064-482C-494D-9AD9-A427AB78A7F0Q38128548-11DA7C5F-C685-4898-B8FD-14CCD5AD17B7Q38204970-4015C1B5-27DE-464A-B290-90A1BB5C4FCBQ38290119-2B290489-579E-4D18-AE0B-D3E5ABE7B3BBQ38494198-7F87E5A1-2F7F-4A2A-9E6A-63DD456FD40FQ40618944-A12CF54B-E398-4FD4-9405-745797F72A1CQ42362519-BAFECC9F-8722-4F42-8024-7CA65507F163Q42725751-892FD959-1190-4791-87F6-E0A8B3AE372EQ50026039-A97C47CE-B17A-477C-89F5-320C555F5421
P2860
Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Diagnostic value of a group of ...... non-alcoholic steatohepatitis.
@ast
Diagnostic value of a group of ...... non-alcoholic steatohepatitis.
@en
type
label
Diagnostic value of a group of ...... non-alcoholic steatohepatitis.
@ast
Diagnostic value of a group of ...... non-alcoholic steatohepatitis.
@en
prefLabel
Diagnostic value of a group of ...... non-alcoholic steatohepatitis.
@ast
Diagnostic value of a group of ...... non-alcoholic steatohepatitis.
@en
P2093
P1476
Diagnostic value of a group of ...... non-alcoholic steatohepatitis.
@en
P2093
C Rinaldi A Lesmana
Ening Krisnuhoni
Irsan Hasan
Laurentius A Lesmana
Nurul Akbar
Unggul Budihusodo
P2860
P304
P356
10.1111/J.1751-2980.2009.00386.X
P50
P577
2009-08-01T00:00:00Z